Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 30;5(1):84.
doi: 10.1038/s41746-022-00633-6.

A novel AI device for real-time optical characterization of colorectal polyps

Collaborators, Affiliations

A novel AI device for real-time optical characterization of colorectal polyps

Carlo Biffi et al. NPJ Digit Med. .

Erratum in

Abstract

Accurate in-vivo optical characterization of colorectal polyps is key to select the optimal treatment regimen during colonoscopy. However, reported accuracies vary widely among endoscopists. We developed a novel intelligent medical device able to seamlessly operate in real-time using conventional white light (WL) endoscopy video stream without virtual chromoendoscopy (blue light, BL). In this work, we evaluated the standalone performance of this computer-aided diagnosis device (CADx) on a prospectively acquired dataset of unaltered colonoscopy videos. An international group of endoscopists performed optical characterization of each polyp acquired in a prospective study, blinded to both histology and CADx result, by means of an online platform enabling careful video assessment. Colorectal polyps were categorized by reviewers, subdivided into 10 experts and 11 non-experts endoscopists, and by the CADx as either "adenoma" or "non-adenoma". A total of 513 polyps from 165 patients were assessed. CADx accuracy in WL was found comparable to the accuracy of expert endoscopists (CADxWL/Exp; OR 1.211 [0.766-1.915]) using histopathology as the reference standard. Moreover, CADx accuracy in WL was found superior to the accuracy of non-expert endoscopists (CADxWL/NonExp; OR 1.875 [1.191-2.953]), and CADx accuracy in BL was found comparable to it (CADxBL/CADxWL; OR 0.886 [0.612-1.282]). The proposed intelligent device shows the potential to support non-expert endoscopists in systematically reaching the performances of expert endoscopists in optical characterization.

PubMed Disclaimer

Conflict of interest statement

C.B., Pi.S., N.N.D., and A.C. are inventors of patents related to the submitted work and are employees of the company manufacturing the device. C.H. is consultant for Medtronic and Fujifilm. Pr.S. is a consultant for Medtronic, Olympus, Boston Scientific, Fujifilm, Lumendi, and receives grant support from Ironwood, Erbe, Docbot, Cosmo Pharmaceuticals, and CDx Labs.

Figures

Fig. 1
Fig. 1. AI device intended use workflow.
The endoscopy video stream flows through the device with no modification or delay (<1.5 μs). In real time (50–60 ms), the device augments the video stream by adding overlay markers to surround areas of interest, such that they can be further inspected by the endoscopist. During colon navigation (1), the endoscopist is focused on exposing the mucosa appropriately in order to facilitate the task of polyp detection. The AI intelligent device activates when a polyp is detected (2, CADe). At this stage, the endoscopist examines the mucosa in order to characterize the lesion and decide on clinical action: if a polyp is framed consistently by the endoscopist, the CADx activates automatically (3) and the histology prediction is added to the green box. After possible endoscopic resection of the polyp (4), navigation is resumed (1) and CADx automatically disengages. These tasks are iterated as a loop until the end of the procedure.
Fig. 2
Fig. 2. ROC curves calculated using the bootstrap method.
From left to right: CADx white light vs non-expert endoscopists, CADx white light vs expert endoscopists, and CADx white light vs CADx blue light. The light band around the ROC curves represents 95% confidence intervals derived by bootstrapping. Black dots represent individual reviewers' performances.
Fig. 3
Fig. 3. Graphical visualization of agreement between reviewer predictions and histology.
Results for polyps with non-adenomatous and adenomatous histology are reported in left and right plots, respectively. In each box, the rightmost pair of bins reports polyps for which 70–100% of the endoscopists' predictions are in agreement with histology, while the leftmost pair of bins reports polyps for which less than 30% of the endoscopists' predictions are in agreement with histology. Each bin pair reports non-experts on the left and experts on the right. The distribution suggests that most of CADx FPs and FNs are polyps where reviewers disagree with each other, or are unanimously in disagreement with histology.
Fig. 4
Fig. 4. Exemplar images of polyps with disputed histology.
Video frames of polyps for which both CADx and all reviewer predictions are in contrast with the histology ground truth. These polyps are considered false negatives (top row—histology: adenoma, CADx prediction: non-adenoma) or false positives (bottom row—histology: non-adenoma, CADx prediction: adenoma) in the reported accuracies.
Fig. 5
Fig. 5. Colonoscopy videos of 165 patients screened in the CHANGE study were considered for the Standalone CADx study.
A total of 544 polyps videoclips from 130 patients was obtained after discarding dropout patients and patients with no polyps. This number was further reduced to 513 polyp videoclips (198 adenomas, 315 non-adenomas) after polyps with no recorded histology or missing videoclips were discarded by scientific annotation experts.

References

    1. Sung H, et al. Global Cancer Statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Kaminski MF, et al. Increased rate of adenoma detection associates with reduced risk of colorectal cancer and death. Gastroenterology. 2017;153:98–105. doi: 10.1053/j.gastro.2017.04.006. - DOI - PubMed
    1. Rex DK, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer. Am. J. Gastroenterol. 2017;112:1016–1030. doi: 10.1038/ajg.2017.174. - DOI - PubMed
    1. Bisschops R, et al. Advanced imaging for detection and differentiation of colorectal neoplasia: European society of Gastrointestinal Endoscopy (ESGE) guideline–update 2019. Endoscopy. 2019;51:1155–1179. doi: 10.1055/a-1031-7657. - DOI - PubMed
    1. Sano Y, et al. Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team. Dig. Endoscopy. 2016;28:526–533. doi: 10.1111/den.12644. - DOI - PubMed